Company / Interest Expense per Share
Oruka Therapeutics, Inc. Interest Expense per Share History
FY2015-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2021
5-year range
$0.00 / $0.00
FY2017-FY2021
Trend
-78.5%
vs FY2020
Sector context
#38 of 43
Health Care
What the data says
Oruka Therapeutics, Inc.'s interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2021). Interest Expense per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2016 to $0.01 in FY2019.
Based on SEC 10-K filings.
0.00 in FY2021 with a 5-year CAGR of +16.4%.
Improved from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +22.8%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
-100.0% below sector average
Key checks
Key Insights
- In FY2021, interest expense per share decreased 78.5% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.00 | -78.5% |
| FY2020 | $0.00 | -57.5% |
| FY2019 | $0.01 | +1929.6% |
| FY2018 | $0.00 | -22.9% |
| FY2017 | $0.00 | +49.5% |
| FY2016 | $0.00 | -55.5% |
| FY2015 | $0.00 | +289.3% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026